A few months ago, in March, American eVTOL maker Pivotal announced a first-of-its-kind program to train paramedics to fly themselves to where they are needed in a single-seat aircraft that can be ...
CellProthera and Alfresa Holdings sign a MoU to advance phase 3 development and future wholesale distribution of ProtheraCytes in Japan: Mulhouse, France Thursday, August 13, 2026 ...
OSF Children’s Hospital in Peoria offers Level IV NICU care, serving Central Illinois families with advanced specialists, research, and support.
For families facing devastating diagnoses, months of waiting for disability benefits can add financial strain to an already overwhelming situation. The Social Security Administration has added 14 rare ...
Planned acquisition leverages existing regulatory and commercial infrastructure and leadership's experience in Fabry therapy commercialization – – ST-920 is a one-time administered AAV gene therapy ...
Our Advanced First Aid course offers people looking for employment or for your employees the necessary knowledge and skills to provide effective emergency care in the workplace or in transit to a ...
Imagine a future in which a stroke survivor regains movement through an intelligent neural interface. A patient with Parkinson's disease receives highly personalized brain stimulation that adapts in ...
Thank you for standing by, and welcome to the Lumexa Imaging Second Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded. And now I'd like to ...
Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics' Fabry Disease Transaction Call. [Operator Instructions] Please be advised that today's conference is being recorded. I ...
On track for September 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for hypoplastic left heart syndrome (HLHS), a rare pediat ...
Over a hundred people gathered at Ford Field on Wednesday for CPR training hosted by the Detroit Lions Foundation and the American Heart Association, all with the goal of preparing more people to ...
Company Highlights Significant Regulatory, Clinical and Strategic Progress Across SkinJect® and Teverelix® Programs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results